Page last updated: 2024-08-17

cycloheximide and decitabine

cycloheximide has been researched along with decitabine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodeur, GM; Eggert, A; Grotzer, MA; Ikegaki, N; Janss, AJ; Marwaha, S; Phillips, PC; Wiewrodt, BR; Zuzak, TJ1
Fang, D; Setaluri, V; Tsuji, Y1
Choi, HY; Jeon, YK; Kim, CW; Kim, H; Kim, JE; Kim, YA; Kim, YN; Park, SO; Park, SS1
Daigle, D; Gradoville, L; Miller, G; Ye, J1
Capper, D; Gaiser, T; Habel, A; Hartmann, C; Herold-Mende, C; Mueller, W; Siegelin, MD; von Deimling, A1

Other Studies

5 other study(ies) available for cycloheximide and decitabine

ArticleYear
Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
    Oncogene, 2000, Sep-21, Volume: 19, Issue:40

    Topics: Adult; Antimetabolites, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspase 9; Caspases; Child; Cycloheximide; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Resistance; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Membrane Glycoproteins; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Protein Synthesis Inhibitors; Receptors, Tumor Necrosis Factor; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; TNF-Related Apoptosis-Inducing Ligand; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2000
Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.
    Nucleic acids research, 2002, Jul-15, Volume: 30, Issue:14

    Topics: Acetamides; Azacitidine; Binding Sites; Blotting, Northern; Cells, Cultured; Cycloheximide; Decitabine; DNA-Binding Proteins; Down-Regulation; Electrophoretic Mobility Shift Assay; Gene Expression Regulation; Humans; Hydroxamic Acids; Luciferases; Melanocytes; Membrane Glycoproteins; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Mutation; Oxidoreductases; Promoter Regions, Genetic; Protein Binding; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; RNA, Messenger; Sequence Deletion; Transcription Factors; Tumor Cells, Cultured

2002
Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma.
    Laboratory investigation; a journal of technical methods and pathology, 2005, Volume: 85, Issue:7

    Topics: Antibodies, Monoclonal; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Calcium-Calmodulin-Dependent Protein Kinases; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Cell Proliferation; Cell Survival; Cycloheximide; Death-Associated Protein Kinases; Decitabine; Down-Regulation; Enzyme Activation; Etoposide; fas Receptor; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Killer Cells, Natural; Lymphoma, T-Cell, Peripheral; Protein Synthesis Inhibitors

2005
De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Journal of virology, 2007, Volume: 81, Issue:17

    Topics: Azacitidine; Blotting, Northern; Cell Line; Cycloheximide; Decitabine; DNA-Binding Proteins; Enzyme Inhibitors; Gene Expression; Herpesvirus 4, Human; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immediate-Early Proteins; Protein Biosynthesis; Protein Kinase C; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Viral; Tetradecanoylphorbol Acetate; Trans-Activators; Viral Proteins; Virus Activation

2007
Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation.
    Acta neuropathologica, 2009, Volume: 117, Issue:4

    Topics: AC133 Antigen; Antigens, CD; Azacitidine; Caspase 3; Caspase 7; Caspase 8; Cell Death; Cycloheximide; Decitabine; DNA Methylation; Down-Regulation; Drug Resistance, Neoplasm; Glioma; Glycoproteins; Humans; Peptides; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Protein Synthesis Inhibitors; RNA, Messenger; Stem Cells; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured

2009